Abstract:Objective To study the expression of cyclooxygenase-2 (COX-2) in the gastric epithelial carcinogensis and its relation with cell apoptosis and proliferation. Methods 15 cases of normal gastric mucosa (NGM), 30 cases of intestinal metaplasia (IM), 30 cases of dysplasia (Dys) and 40 cases of gastric cancer (GC) were used in this study. The expressions of COX-2 and proliferating cell nuclear antigen (PCNA) were detected by immunohistochemical SABC method, and cell apoptosis was measured by TUNEL. Results The expression level of COX-2 gradually increased from NGM, IM, Dys to GC. The positive rate of COX-2 in GC was 67.5%, 13.3% in NGM, and 33.3% in IM. There was a significant difference in COX-2 expression between GC and IM, GC and NGM(P0.05). Cell apoptosis index(AI) was 2.8±0.6 in GC. AI in GC was the lowest among all the pathological lesions (P0.01). Proliferation index (PI) from NGM, IM, Dys to GC also had an increasing tendency, and there were significant differences in PI between GC and the other precancerous lesions (P0.01). There was no significant difference in COX-2 expression among various precancerous lesions (P0.05). The expression of COX-2 in poorly differentiated cancer was markedly higher than that in well differentiated cancer (P0.05). The expression of both COX-2 and PI was closely correlated with the lymph node metastasis and vascular invasion of GC (P0.05). From NGM to IM, COX-2 expression level was positively correlated with AI (r=0.55,P0.05), but from Dys to GC, the negative correlation between COX-2 expression level and AI was observed (r=-0.56,P0.05). During gastric epithelial carcinogenesis, COX-2 expression was positively correlated with PI(r=0.61,P0.05). Conclusion COX-2 expression gradually increased during gastric epithelial carcinogenesis, and up-regulation of COX-2 may be an early event in this process. The expression level of COX-2 and PI may be helpful for evaluating the malignant degree metastasis and prognosis of GC. At the different stages of gastric carcinogenesis, COX-2 could stimulate cell proliferation, but at the early stages it promoted cell apoptosis, and inhibited cell apoptosis at the late stage.

Expressions of Cyclooxygenase-2 in Reflux Esophagitis and Esophageal Carcinoma

Expression of cyclooxygenase 2 in colorectal cancer

Relationship Between Expression of COX-2 and Clinicopathological Features in Esophageal Carcinoma

Relationship Between Expression of COX-2 and Clinicopathological Characteristics in Human Gastric Cancer

Cyclooxygenase-2 expression in squamous dysplasia and squamous cell carcinoma of the esophagus.

[Expression of Cyclooxygenase-2 in Esophageal Squamous Cell Carcinogenesis].

Expression of P53, P16 and Cyclooxygenase-2 in Esophageal Cancer with Tissue Microarray

Expression of Cyclooxygenase-2 in Esophageal Carcinoma and Its Correlation with Angiogenesis

Relationship between COX-2 and cell cycle-regulatory proteins in patients with esophageal squamous cell carcinoma.

Expression of the cyclooxygenase-2 gene and its clinical significance in non-small cell lung cancer

Cyclooxygenase-2 is over-expressed in Chinese esophageal squamous cell carcinoma, and correlated with NF-κB: An immunohistochemical study

Relationship Between COX-2 Expression and Clinicopathological Features of Colorectal Cancers

Correlation of Cyclooxygenase-2 Mrna Expression with Occurrence and Development of Esophageal Carcinoma

Cyclooxygenase-2 expression correlates with angiogenesis and vascular endothelial growth factor-A in non-small cell lung cancer

Expression and Significance of COX-2 and VEGF in Esophageal Squamous Cell Carcinoma

Expression of COX-2 in the Carcinogenesis of Gastric Epithelia and Its Correlation with Cell Apoptosis and Proliferation

Relationship between the expressions of hypoxia inducible factor 1-α and cyclooxygenase-2 and the biological behavior in esophageal squamous carcinoma

Correlation of Expression of COX-2 to Clinical Pathological Characters and Its Catalytic Products in Gastric Carcinoma

Correlation Between Expression of Cyclooxygenase-2 and Invasiveness and Metastasis in Gastric Carcinoma

[Expressions of Cyclooxygenase-2 and Cholecystokinin-B Receptor Mrna in Human Colonic Cancer and Their Significances].

Expression of epidermal growth factor receptor and cyclooxygenase-2 and their correlations in gastric carcinoma